Kidney Function Test Market worth $790.1 Million Growing at a CAGR of 6.1%

PUNE, India, 2020-May-15 — /EPR Network/ —

The report “Kidney Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User -Global Forecast to 2022″, is expected to reach USD 790.1 Million by 2022 from an estimated USD 586.5 Million in 2017, at a CAGR of 6.1%

Growth in the Renal Function Test Market can primarily be attributed to factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, rapid growth in the geriatric population, and the rise in alcohol consumption are driving the growth of the market.

Browse 90 market data Tables and 33 Figures spread through 126 Pages and in-depth: Request Research Sample pages – https://www.marketsandmarkets.com/requestsampleNew.asp?id=40239083

By product, the dipsticks segment is expected to dominate the market in 2017

By product, the market is categorized into dipsticks, reagents, and disposables. Dipsticks are expected to account for the largest share of the market in 2017, they are also expected to grow at the highest CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as the cost-effectiveness of dipstick testing and its widespread applications across specializations.

By type, the urine tests segment is expected to account for the largest share of the market in 2017

Based on type, the Kidney Function Test Market is segmented into urine and blood tests. Urine tests are further categorized into urine protein, creatinine clearance, and microalbumin. Similarly, blood tests are categorized into serum creatinine, glomerular filtration rate (GFR), and blood urea nitrogen (BUN).

In 2017, the urine tests segment is expected to account for the largest share of the market. This segment is also expected to grow at the highest CAGR during the forecast period. Factors contributing to the large share and high growth rate of this segment include increasing usage of urine dipsticks analysis, the ease in sample collection technique compared to blood samples, and this method also has a very limited risk of infection.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40239083

North America to dominate the market

North America is expected to account for the largest share of the global renal function test market. The large share of the North American market is attributed to the increasing incidence of chronic diseases, rising prevalence of hypertension, growing incidence of diabetes in the US, and increasing initiatives by the Canadian government for the treatment of kidney diseases.

The prominent players in the global kidney function/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK).